Travere Therapeutics, Inc.TVTXNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank43
5Y CAGR+33.7%
Studio
Year-over-Year Change

Year-over-year total asset growth rate

5Y CAGR
+33.7%/yr
Long-term compound
Percentile
P43
Within normal range
vs 5Y Ago
4.3x
Strong expansion
Streak
1 yr
Consecutive growthRecovering
PeriodValue
20251.86%
2024-24.69%
202317.30%
2022-13.40%
202127.85%
20200.44%
2019-14.72%
201836.29%
2017-0.94%
20162.51%